Abstinence · cannabis dependence
Buspirone showed no clear difference in participants abstinent at end of treatment compared with placebo (low certainty).
1 finding from 1 review
Participants with at least some Side Effects · cannabis dependence
Buspirone showed no clear difference in participants experiencing adverse effects compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · cannabis dependence
Buspirone showed no clear difference in participants withdrawn due to adverse effects compared with placebo (low certainty).
1 finding from 1 review
Completion of scheduled treatment · cannabis dependence
Buspirone showed no clear difference in completion of scheduled treatment compared with placebo (low certainty).
1 finding from 1 review
Benzodiazepine discontinuation, end of intervention · adults who withdraw from chronic benzodiazepine use
Buspirone showed no clear difference in benzodiazepine discontinuation, end of intervention compared with placebo (low certainty).
1 finding from 1 review
Benzodiazepine discontinuation, longest · adults who withdraw from chronic benzodiazepine use
Buspirone showed no clear difference in benzodiazepine discontinuation, longest compared with placebo (low certainty).
1 finding from 1 review
Benzodiazepine withdrawal symptoms, end of intervention · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review
Benzodiazepine withdrawal symptoms, longest · adults who withdraw from chronic benzodiazepine use
1 finding from 1 review